SelectQuote, Inc. (SLQT)
Financials · Insurance distribution & healthcare services · NYSE
A technology-driven insurance marketplace for seniors that is diversifying into integrated healthcare services like pharmacy and chronic care management.
What SelectQuote, Inc. does
SelectQuote is a technology-enabled, direct-to-consumer insurance distribution and healthcare services platform. The company operates a senior health, life, and home/auto insurance exchange that connects consumers with insurance carriers, while also providing integrated healthcare services, including a specialty pharmacy (SelectRx) and chronic care management through its Healthcare Select and SelectPatient Management units. By leveraging proprietary AI-driven marketing and lead routing technology, SelectQuote focuses on maximizing the lifetime value of insurance commissions and scaling its patient-centric healthcare service offerings.
Recent developments
For fiscal year 2027, the company provided guidance expecting revenue between $1.35 billion and $1.45 billion and operating cash flow exceeding $60 million. The company successfully implemented technology-enabled efficiencies expected to drive over $30 million in annual expense savings. Additionally, the company is actively working to regain compliance with NYSE minimum share price standards after receiving a notification of non-compliance in March 2026.
From SelectQuote, Inc.'s filing of 2026-08-25.
Themes: senior healthcare, Medicare Advantage distribution, AI-powered marketing / lead generation, specialty pharmacy services, chronic care management, digital health transformation
Fundamentals
- Price$0.3039 as of 2026-10-20 close
- Market cap$54M as of 2026-07-31 (share count; price 2026-10-20)
- 1-year return-84.7% 2025-10-20 close $1.98 → 2026-10-20 close $0.3039
- P/En/a negative earnings
- Net margin+3.8% FY2026, SEC XBRL
- ROE+17.7% FY2026, SEC XBRL
- ROIC+8.6% NOPAT / (debt + equity - cash), average capital — 10-K FY2026 (year ended 2026-06-30)
- Debt / equity1.05 borrowings, leases excluded / equity — 10-Q/10-K balance sheet 2026-06-30
- Revenue growth (YoY)+6.0% FY2026, SEC XBRL
- Revenue CAGR (3y)+17.3% SEC XBRL
- Beta1.55 as of 2026-09-02
- Last reported earnings2026-08-25 SEC EDGAR Form 8-K (Item 2.02)
Dividend: at least 3 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How SLQT compares in its sector
- net profit marginbottom 25% 343 covered Financials peers, as of 2026-09-02
- operating marginbottom 25% 121 covered Financials peers, as of 2026-09-02
- return on equitytop 25% 558 covered Financials peers, as of 2026-09-02
- 3-year revenue CAGRmiddle range 347 covered Financials peers
- free cash flow (absolute dollars, latest fiscal year)middle range 430 covered Financials peers, as of FY2026
Position among covered Financials companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Dividend coverage
Not assessed — last reported dividend predates the accounts. The most recent fiscal year in which SLQT reported a dividend payment is FY2020, while its reported financial statements run through FY2026. Coverage is therefore not assessed for the latest year — an FY2020 ratio would not describe SLQT today.
Coverage is derived from reported SEC EDGAR XBRL figures, comparing dividends paid against net income and free cash flow for the SAME fiscal year. It is not shown here because the latest fiscal year with a reported dividend payment (FY2020) is older than the latest year of reported financial statements (FY2026), so any ratio would describe an out-of-date year. Informational only — not financial advice.
Quarterly results
| Quarter | Revenue | Operating income | Net income | Diluted EPS | Operating cash flow | Capex |
|---|---|---|---|---|---|---|
| Q4 FY2026 2026-06-30 | $322M† | $3M† | -$17M† | -$0.17† | -$3M† | $1M† |
| Q3 FY2026 2026-03-31 | $431M | $36M | $40M | $0.11 | $57M† | $947000† |
| Q2 FY2026 2025-12-31 | $537M | $75M | $69M | $0.26 | $52000† | $1M† |
| Q1 FY2026 2025-09-30 | $329M | -$41M | -$30M | -$0.26 | -$22M | $1M |
| Q4 FY2025 2025-06-30 | $345M† | -$13M† | $13M† | -$0.12† | -$37M† | $501000† |
| Q3 FY2025 2025-03-31 | $408M | $22M | $26M | $0.03 | $71M† | $949000† |
| Q2 FY2025 2024-12-31 | $481M | $71M | $53M | $0.30 | -$29M† | $299000† |
| Q1 FY2025 2024-09-30 | $292M | -$12M | -$45M | -$0.26 | -$17M | $442000 |
† Not filed as a discrete quarter: derived from the company's own year-to-date figures (for example the fourth quarter as the fiscal year minus the first nine months). A derived per-share figure is approximate, because the share count moves within the year.
Balance sheet at 2026-06-30
- Cash and equivalents$16M
- Total debt$370M borrowings only; leases excluded
- Net debt$354M total debt − cash − short-term investments
From the company's own SEC 10-Q and 10-K filings (XBRL), re-read every week. Figures in US dollars as filed; informational only — not financial advice.
How SelectQuote, Inc. looks technically
SelectQuote, Inc. (SLQT) is trading 63.8% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 357 trading days ago — a "death cross", a bearish long-term signal. A strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 50, with sellers in control. Momentum is beaten down — its 14-day RSI (a 0–100 momentum gauge) is 23, in oversold territory (below 30). It just made a new 20-day low, breaking below its recent trading range. It is 1.3% above its 52-week low (its lowest price of the past year).
Trend
7
| Distance from the 200-day | it is trading 63.8% below its 200-day average, the long-term trend line — a long-term downtrend | -63.8% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $0.5073 | $0.5073 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $0.84 | $0.84 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing low 22 calendar days ago — the swings before that are what the structure reading is measured on | 22 sessions |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 357 trading days ago — a "death cross", a bearish long-term signal | 357 sessions |
| Trend strength (14-day ADX) | a strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 50, with sellers in control | 49.7 |
Momentum
3
| 14-day RSI | momentum is beaten down — its 14-day RSI (a 0–100 momentum gauge) is 23, in oversold territory (below 30) | 23.0 |
|---|---|---|
| Position in its 14-day range | it is trading right at the bottom of its 14-day range ($0.3 to $0.44) — its "stochastic" reading is 3 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 2.8 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is right at the zero line — momentum is balanced | 0 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $2.22 | $2.22 |
|---|---|---|
| From the 52-week high | it is 86.3% below its 52-week high (its highest price of the past year) | -86.3% |
| Above the 52-week low | it is 1.3% above its 52-week low (its lowest price of the past year) | +1.3% |
| Below the 52-week high | it is 86.3% below its highest point of the past year | 86.3% |
| Since a 20-day breakout | it just made a new 20-day low, breaking below its recent trading range | 1 session |
| Since a 55-day breakout | it just made a new 55-day low, breaking below its recent trading range | 1 session |
| All-time high | its highest closing price on record is $33.00 (set on 2021-04-13) | $33.00 |
| Given back of the 52-week move | over the past year its closes ranged ($0.3039 to $2.13), and it has recovered essentially none of its fall from last year’s high — 0% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $1.43 to $1.49. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 0.0% |
| From the all-time high | it is 99.1% below its all-time high | -99.1% |
| Nearest price level | it is trading 164.9% below a resistance level at $0.805 — a price it turned at twice since 2026-05-04, most recently on 2026-08-03. Since 2024-10-21 it has 0 such levels below the current price and 10 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +164.9% |
| All-time low | its lowest closing price on record is $0.3 (set on 2026-10-20) | $0.3 |
| Above the all-time low | it is 1.3% above its all-time low | +1.3% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are about average versus its own recent 6-month history | 68th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.0284 between its high and its low — about 9.4% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.0284 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $0.3 and $0.46 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $0.3 – $0.38 – $0.46 |
| Typical daily range (% of price) | its price moves about 9.4% in a typical session — among the most volatile in the catalog. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 9.4% |
| Stretch from the 200-day average | it is trading 18.9 daily ranges below its 200-day average price (63.8% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 18.9 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.70× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | not available for this company yet | n/a |
Candlestick patterns
1
| Since a bearish engulfing | 2 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 2 sessions ago |
|---|
Price gaps
3
| Gap at the open | it opened on 2026-10-20 2.0% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | -2.0% |
|---|---|---|
| Open gap | it gapped 7.8% below the previous close 4 sessions ago and has not traded back through the level it left behind at 0.35 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | -7.8% |
| Gap filled | a 2.7% gap down opened on 2026-10-08 has been "filled" 8 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 8 sessions ago |
Price streaks
1
| Closing streak | it has closed lower 3 sessions in a row, a -10.62% move over the run — an unbroken run of down days, which describes what has already happened and says nothing about the next session | 3 sessions down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 35.9 percentage points (the stock lost 34.9% while the market gained 1.0%) | -35.9% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 61.0 percentage points (the stock lost 57.3% while the market gained 3.6%) | -61.0% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 68.1 percentage points (the stock lost 59.6% while the market gained 8.5%) | -68.1% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 99.2 percentage points (the stock lost 84.7% while the market gained 14.6%) | -99.2% |
Signal agreement
2
| Bullish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bullish state: its RSI momentum gauge is oversold (a beaten-down reading), near the bottom of its 14-day range (oversold) — these describe past price behaviour, not a forecast | 2 of 9 |
|---|---|---|
| Bearish technical signals | 6 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, a fresh 20-day low, a strong downtrend, with sellers in control, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 6 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 50% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-14 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is thick, spanning 29.4% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross. | -49.8% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 66% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $0.8891 — a volume-weighted average of daily closes over 196 sessions, not a true tick-by-tick VWAP. | -65.8% |
|---|---|---|
| Vs the average paid since it last reported | the price is 34% below the average price paid since it last reported on 2026-08-25 (its 10-K), so the typical buyer over that stretch is under water. That average is $0.4615 — a volume-weighted average of daily closes over 40 sessions, not a true tick-by-tick VWAP. | -34.1% |
Price levels it has turned at before
SLQT last closed at $0.3039 on 2026-10-20. Since 2024-10-21 it has turned at 0 prices below its last close and 10 above; the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $0.805 | Resistance | 164.9% above the last close | turned there twice · 2026-05-04 to 2026-08-03 |
| $0.944 | Resistance | 210.6% above the last close | turned there twice · 2026-02-20 to 2026-05-26 |
| $1.33 | Resistance | 339.3% above the last close | turned there twice · 2025-11-20 to 2026-01-08 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
No Elliott-wave labelling currently fits its swings: the recent highs and lows do not satisfy the three rules a five-wave count has to obey, so there is no count to show rather than a count we are unsure about.
Read from daily closes as of 2026-10-20.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Trading below the 50-day moving average · Oversold (14-day RSI below 30) · Near the 52-week low · Pulled back from the 12-month high · Broke down to a new 20-day low | Learn: moving average · golden cross · adx · rsi · breakout · fifty two week high low
Based on daily closing prices as of 2026-10-20. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Mean price target$2.13 range $0.5 – $3.00; median $2.50
Analyst estimates, as of 2026-10-19. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for SLQT
- Consensus EPS estimate-$0.26 next reporting period, as of 2026-10-19
- Estimate change, 30 days$0.00 from -$0.26, on 2026-09-14, 35-day window
- Readings revised upward0% of 7 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Risk of NYSE delisting due to share price falling below $1.00 minimum requirements.","Concentration of revenue in senior Medicare Advantage insurance distribution which is subject to regulatory and carrier policy changes.","Significant competition in the insurance distribution and pharmacy services markets."]
What changed in the latest 10-Q
AI-assisted comparison of SLQT's 10-Q filed 2026-05-05 against the prior one filed 2026-02-05.
Management's Discussion & Analysis (MD&A)
- Added:
- MA and MS plans accounted for 90% of approved Senior policies for three months ended March 31, 2026 (newer filing, 2026-05-05)
- MA and MS plans accounted for 90% of approved Senior policies for nine months ended March 31, 2026 (newer filing, 2026-05-05)
- Reference to comparison with 2025 periods for three months and nine months ended March 31 (newer filing, 2026-05-05)
- Removed:
- MA and MS plans accounted for 93% of approved Senior policies for three months ended December 31, 2025 (older filing, 2026-02-05)
- MA and MS plans accounted for 93% of approved Senior policies for six months ended December 31, 2025 (older filing, 2026-02-05)
- Reference to comparison with 2024 periods for three months and six months ended December 31 (older filing, 2026-02-05)
- Reworded:
- Period reference changed from 'three months ended December 31, 2025' to 'three months ended March 31, 2026'
- Period reference changed from 'six months ended December 31, 2025' to 'nine months ended March 31, 2026'
- Comparison years changed from 2025 and 2024 to 2026 and 2025
- MA and MS plan percentage changed from 93% to 90% for most recent three-month period
- Notes:
- Both documents appear truncated at the end; comparison is limited to the provided text
- The changes reflect different reporting periods (Q4 2025 year-end in older filing versus Q1 2026 quarter-end in newer filing)
Risk Factors
- Added:
- Newer filing shows table of contents page numbers: Item 1A Risk Factors on page 64, Item 6 Exhibits on page 66, Signatures on page 67 (filed 2026-05-05)
- Newer filing balance sheet dated March 31, 2026 with comparison to June 30, 2025 (filed 2026-05-05)
- Newer filing consolidated statements of comprehensive income for three months and nine months ended March 31, 2026 and 2025 (filed 2026-05-05)
- Newer filing statements of changes in shareholders' equity for three months and nine months ended March 31, 2026 (filed 2026-05-05)
- In newer filing, cash decreased from $35,733 thousand to $35,211 thousand (filed 2026-05-05)
- In newer filing, accounts receivable increased from $151,388 thousand to $234,291 thousand (filed 2026-05-05)
- In newer filing, commissions receivable-current decreased from $132,077 thousand to $76,836 thousand (filed 2026-05-05)
- In newer filing income statement, nine months ended March 31, 2026 shows net income of $79,031 thousand with net income attributable to common shareholders of $24,649 thousand (filed 2026-05-05)
- Removed:
- Older filing shows table of contents page numbers: Item 1A Risk Factors on page 63, Item 6 Exhibits on page 64, Signatures on page 65 (filed 2026-02-05)
- Older filing balance sheet dated December 31, 2025 with comparison to June 30, 2025 (filed 2026-02-05)
- Older filing consolidated statements of comprehensive income for three months and six months ended December 31, 2025 and 2024 (filed 2026-02-05)
- Older filing statements of changes in shareholders' equity for three months and six months ended December 31, 2025 (filed 2026-02-05)
- In older filing income statement, six months ended December 31, 2025 shows net income of $38,834 thousand with net income attributable to common shareholders of $3,227 thousand (filed 2026-02-05)
- Reworded:
- Comparison period in balance sheet changed from December 31, 2025 to March 31, 2026 in newer filing (filed 2026-05-05)
- Income statement period changed from three months and six months ended December 31, 2025 to three months and nine months ended March 31, 2026 in newer filing (filed 2026-05-05)
- Preferred stock liquidation preference increased from $394.2 million at December 31, 2025 to $408.4 million at March 31, 2026 in newer filing (filed 2026-05-05)
- Notes:
- These are different quarterly reporting periods (Q4 2025 year-end filing versus Q1 2026 quarter-end filing) rather than revisions of the same period
- Financial statement line items and values are different due to different reporting dates, not due to restatements or revisions
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales recorded in the last 90 days, of which we have read Form 4 filings through 2026-10-16. The 5 days since 2026-10-16 have not been checked yet.
- Last 180 days · read to 2026-10-160 buys · 1 sell ($4080) — 1 selling insider
Most recent open-market transaction: 2026-05-19. Based on Form 4 filings read through 2026-10-16; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about SLQT's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
5 institutional 13F filers reported holding SLQT as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 5,025,975
- Reported value $4,227,348
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 2 increased, 3 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about SLQT's institutional holders → See what each manager we track holds →
Short interest (FINRA)
SLQT had 1,861,894 shares of reported short interest as of the 2026-09-30 FINRA settlement date (delayed, bi-monthly; not real-time).
SLQT had 1.05% of its shares outstanding sold short as of the 2026-09-30 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 1.81 days to cover at the same settlement.
- Reported short interest (shares) 1,861,894
- Short interest (% of shares outstanding) 1.05%
- Prior settlement (shares) 1,660,548
- Reported change 12.13%
- Days to cover (reported) 1.81
Reported to FINRA as of the 2026-09-30 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- eHealth (EHTH)
- GoHealth (GOCO)
- CVS Health (CVS)
- Walgreens Boots Alliance (WBA)
- Oscar Health (OSCR)
- Accolade (ACCD)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare SLQT vs…
Frequently asked questions
What does SelectQuote, Inc. (SLQT) do?
SelectQuote is a technology-enabled, direct-to-consumer insurance distribution and healthcare services platform. The company operates a senior health, life, and home/auto insurance exchange that connects consumers with insurance carriers, while also providing integrated healthcare services, including a specialty pharmacy (SelectRx) and chronic care management through its Healthcare Select and SelectPatient Management units.
What sector is SelectQuote, Inc. (SLQT) in?
SelectQuote, Inc. (SLQT) is classified in the Financials sector. Its industry is Insurance distribution & healthcare services. It trades on NYSE.
Who are SelectQuote, Inc.'s (SLQT) competitors?
Notable peers of SelectQuote, Inc. (SLQT) include eHealth, GoHealth, CVS Health, Walgreens Boots Alliance and Oscar Health. This peer set is informational only — not financial advice.
Is SelectQuote, Inc. (SLQT) overbought or oversold right now?
SelectQuote, Inc. (SLQT) is currently in oversold territory (its 14-day RSI is 23, below 30) (as of 2026-10-20). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on SLQT come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest; prices are market data, as of 2026-09-02; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.